Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Influenza Other Respir Viruses ; 2(2): 53-60, 2008 Mar.
Article in English | MEDLINE | ID: mdl-19453472

ABSTRACT

A patch containing a trivalent inactivated influenza vaccine (TIV) was prepared in a dried, stabilized formulation for transcutaneous delivery. When used in a guinea pig immunogenicity model, the dry patch was as effective as a wet TIV patch in inducing serum anti-influenza IgG antibodies. When the dry TIV patch was administered with LT as an adjuvant, a robust immune response was obtained that was comparable with or better than an injected TIV vaccine. When stored sealed in a nitrogen-purged foil, the dry TIV patch was stable for 12 months, as measured by HA content, under both refrigerated and room temperature conditions. Moreover, the immunological potency of the vaccine product was not affected by long-term storage. The dry TIV patch was also thermostable against three cycles of alternating low-to-high temperatures of -20/25 and -20/40 degrees C, and under short-term temperature stress conditions. These studies indicate that the dry TIV patch product can tolerate unexpected environmental stresses that may be encountered during shipping and distribution. Because of its effectiveness in vaccine delivery and its superior thermostable characteristics, the dry TIV patch represents a major advance for needle-free influenza vaccination.


Subject(s)
Influenza Vaccines/administration & dosage , Influenza Vaccines/immunology , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/pharmacology , Administration, Cutaneous , Animals , Antibodies, Viral/blood , Bacterial Toxins/administration & dosage , Bacterial Toxins/pharmacology , Desiccation , Dosage Forms , Drug Stability , Drug Storage , Enterotoxins/administration & dosage , Enterotoxins/pharmacology , Escherichia coli Proteins/administration & dosage , Escherichia coli Proteins/pharmacology , Female , Guinea Pigs , Immunoglobulin G/blood , Vaccines, Inactivated/immunology
2.
Mol Pharm ; 2(6): 491-9, 2005.
Article in English | MEDLINE | ID: mdl-16323956

ABSTRACT

Respiratory syncytial virus (RSV) was studied as a function of pH (3-8) and temperature (10-85 degrees C) by fluorescence, circular dichroism, and high-resolution second-derivative absorbance spectroscopies, as well as dynamic light scattering and optical density as a measurement of viral aggregation. The results indicate that the secondary, tertiary, and quaternary structures of RSV are both pH and temperature labile. Derivative ultraviolet absorbance and fluorescence spectroscopy (intrinsic and extrinsic) analyses suggest that the stability of tertiary structure of RSV proteins is maximized near neutral pH. In agreement with these results, the secondary structure of RSV polypeptides seems to be more stable at pH 7-8, as evaluated by circular dichroism spectroscopy. The integrity of the viral particles studied by turbidity and dynamic light scattering also revealed that RSV is more thermally stable near neutral pH and particularly prone to aggregation below pH 6. By combination of the spectroscopic data employing a multidimensional eigenvector phase space approach, an empirical phase diagram for RSV was constructed. The pharmaceutical utility of this approach and the optimal formulation conditions are discussed.


Subject(s)
Hydrogen-Ion Concentration , Respiratory Syncytial Virus, Human/physiology , Circular Dichroism , Hot Temperature , Humans , Light , Respiratory Syncytial Virus, Human/growth & development , Respiratory Syncytial Virus, Human/ultrastructure , Scattering, Radiation , Spectrometry, Fluorescence , Spectrophotometry , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL
...